Autonomic Nervous System Disorders
Theravance Biopharma Ireland Limited is engaged in clinical research focused on neurogenic orthostatic hypotension, a condition linked to impaired autonomic regulation of blood pressure and symptoms related to standing.
- Symptomatic nOH
- Orthostatic intolerance
- Blood pressure dysregulation
The sponsor’s research activity in this area is closely associated with disorders affecting autonomic function, including patients with multiple system atrophy.
Multiple System Atrophy
The clinical programme includes studies in multiple system atrophy, with attention to the vascular and neurological complications that contribute to symptomatic burden in affected participants.
- Neurodegenerative disease
- Autonomic failure
- Postural symptoms
This area reflects interest in managing manifestations of MSA that interfere with daily function and cardiovascular stability.
Cardiovascular Symptom Control
Research activity also addresses cardiovascular symptoms arising from impaired autonomic control, with a focus on standing-related dizziness, lightheadedness, and related hemodynamic effects.
- Orthostatic dizziness
- Syncope-related symptoms
- Hemodynamic instability
These interests align with therapeutic strategies aimed at improving symptom persistence and functional comfort in people living with nOH.
Neurology-Related Therapeutics
The sponsor’s clinical research landscape sits within neurology, particularly conditions where autonomic dysfunction intersects with progressive neurological disease.
- Autonomic symptoms
- Neurological disability
- Patient-reported symptom burden
Its funded research reflects a therapeutic interest in disorders where neurological and cardiovascular manifestations occur together.
